Company Overview

Company name: Curaleaf (CNQ: CURA)
Description: Operator of a company focused on the therapeutic value of medical cannabis intended to ease human suffering. The company’s offerings include developing patient-centric full-scale cannabis operations, along with core competencies in cultivation, manufacturing, dispensing, testing and medical cannabis research, enabling the patients and consumers to receive compassionate care in a respectful and nurturing environment.
Year founded: 2009
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Wakefield
State: Massachusetts
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 398.90
Business status: Generating Revenue
Ownership: Publicly Held
Exchange: CNQ
Ticker: CURA
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million) -45.38
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA): -41.67
Fiscal period: TTM 3Q2018
Financing Status: The company acquired Lead Ventures through a reverse merger, resulting in the combined entity trading on the CSE under the ticker symbol of CURA on August 16, 2018.
Number of active investors:
Profile last updated: 28-Nov-2018
Last known valuation: 28.57
Last known valuation date: 31-Jul-2013